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EXECUTIVE SUMMARY 
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Background  
  
Medication errors in general practice are an important and expensive preventable cause of 
patient safety incidents associated with morbidity, hospitalisations and deaths. A recent 
study in English general practices identified errors in 5% of prescription items, with one in 
550 items containing a potentially life-threatening error. Given the prevalence of medication 
errors, and the severity of harm associated with these, there is an urgent need to implement 
interventions known to correct these errors. A pharmacist-led information technology 
intervention for medication errors in general practice (‘PINCER’) was found, in a cluster 
randomised controlled trial, to be acceptable, effective and cost-effective in reducing rates 
of hazardous prescribing. The PINCER intervention involves searching GP clinical systems 
using automated computerised prescribing safety indicators to identify patients at risk from 
their prescriptions, and then acting to correct the problems with pharmacist support. Prior 
to nationwide adoption, it is important to assess the effectiveness of the PINCER 
intervention in a large-scale rollout as the conditions in routine care may be different to 
those in the trial. The aim of this evaluation was therefore to determine whether PINCER is 
effective at reducing rates of hazardous prescribing when rolled out at scale, understand 
how and why the intended change did or did not occur, and to identify any unintended 
consequences of the intervention.   
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Methods  
  
A Quality Improvement Collaborative (QIC) approach was used to implement the PINCER 
intervention whereby an expert team, using structured activities, engaged clinicians and 
pharmacy teams to effect improvement in specific areas of practice. The QIC design was 
based on a logic model and programme theory. Support was provided in the form of 
education, feedback and opportunities for shared learning. Eleven prescribing safety 
indicators were used in the PINCER implementation, and these differed from those used in 
the original trial. They focused on types of hazardous prescribing associated with serious 
harm outcomes such as gastrointestinal bleeding, exacerbation of asthma, exacerbation of 
heart failure, stroke in patients with dementia, and acute kidney injury.  
  
We employed a mixed-methods approach. Quantitative methods were used to investigate 
what, if any, changes occurred in potentially hazardous prescribing over time, before, during 
and after the intervention was introduced in participating CCG practices. Qualitative 
methods were used to explore contextual factors for implementation of PINCER, assess its 
acceptability and feasibility in a range of settings and determine what organisational factors 
(at CCG or practice level) enhanced its effects.  
  
Improvement was measured using anonymised routinely recorded data from general 
practices collected retrospectively, at three monthly time points over a four-year period  from 
two years prior to the intervention starting in any of the practices to after the intervention 
completing in all practices. The main outcome measure was changes in the proportion of 
patients with at least one type of potentially hazardous prescribing. Changes in rates of 
potentially hazardous prescribing for 11 prescribing safety indicators were also described. 
The data were modelled using multilevel logistic regression with practices and repeated 
measurements adjusted for as random-effects. Multilevel logistic regression models 
adjusting for secular trends were also fitted. Interrupted time series analysis was undertaken 
to investigate changes in rates of potentially hazardous prescribing in the lead up to the 
PINCER intervention, in the first quarter following the anticipated start of the intervention, 
and the period after this.  
  
The participants for the qualitative evaluation included members of the implementation 
team, external strategic leaders, CCG pharmacists and practice staff. Participant 
recruitment employed the use of representative and purposive sampling, the latter being 
achieved through desk-based profiling using available data to produce typology 
frameworks. Drawing on concepts within Implementation Science, such as Damschroder et 
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al.’s consolidated framework, data were collected through semi-structured interviews, focus 
groups and an observation of a meeting of CCG pharmacy leads. Analysis of the themes 
within the data identified lessons about the implementation of PINCER across the East 
Midlands at ‘scale and pace’, including barriers and facilitators, timeliness, fidelity and 
transferability. As part of the qualitative evaluation, PINCER leads and members of the 
implementation team were invited to attend a half-day workshop for the development of a 
study logic model. The outcome of the workshop was the creation of an updated logic model 
for the project which was used to refine the appraisal design and provide formative feedback 
to local stakeholders. 
 
Results  
 
Twelve Clinical Commissioning Groups (CCGs) implemented the PINCER intervention in 
370 general practices between September 2015 and April 2017. A total of 2.97 million 
patient records were searched and 22,105 instances of potentially hazardous prescribing 
were identified. Quarterly retrospective data were collected at 16 time points from 343 
general practices commencing 30 November 2013 and ending 31 August 2017.   
  
Statistical process control charts showed reductions in rates of hazardous prescribing over 
the duration of the study for most of the CCGs in particular for prescribing safety indicators 
associated with gastrointestinal bleeding and prescription of non-steroidal anti-inflammatory 
drugs (NSAIDs) to patients with chronic kidney disease.   
  
Multilevel logistic regression analysis, taking account of  clustering by practices, indicated 
that the PINCER intervention was associated with a reduction of around 24% in the 
proportion of patients exposed to at least one type of hazardous prescribing (Odds ratio 
0.756, 95% CI: 0.749, 0.763). The figure was reduced to around 10% after taking account 
of secular trends, CCG, deprivation and list size (Odds ratio 0.902, 95% CI: 0.890, 0.914). 
Reductions in hazardous prescribing were most notable in relation to prescribing safety 
indicators associated with risk of gastrointestinal bleeding, where the overall reduction was 
around 31% (Odds ratio 0.682, 95% CI: 0.661, 0.704), and 14% after taking account of 
secular trends and additional confounders (Odds ratio 0.859, 95% CI: 0.834, 0.884). The 
interrupted time series analysis showed that (after controlling for baseline level and trend) 
there were reductions in hazardous prescribing for five of the 11 prescribing safety 
indicators including those associated with risk of gastrointestinal bleeding, and the 
prescription of oral NSAIDs in patients with either heart failure or chronic kidney disease (a 
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statistically significant reduction in hazardous prescribing for three of the indicators, and a 
borderline statistically significant reduction for two of the indicators). 
  
Thirty-five participants took part in an interview (n=19), focus groups (n=10) or were 
observed (n=6) as part of a meeting of CCG pharmacist leads. All the CCG interviews were 
with pharmacists. The practice interviews comprised four GPs, one pharmacist who was 
solely based in practice (some pharmacists had practice and CCG roles) and one practice 
manager.   
  
The qualitative analysis showed that the engagement of different groups of stakeholders, 
at different points in the implementation of the PINCER intervention, was crucial to the 
success of the implementation. Different aspects of the PINCER intervention, and the 
participants’ perceived need of the intervention, response to peer pressure, safety culture 
and a strong desire to engage in patient safety initiatives, were favourable factors for the 
implementation of PINCER. Where PINCER was implemented, the resulting impact was not 
only in identifying and resolving instances of hazardous prescribing, but also in bringing 
about changes in systems and processes within practices and CCGs.   
  
Implementation was threatened, and at times halted, when resource pressure and cost-
saving initiatives dominated. Availability of adequate resources such as staff time and/or 
availability and a simplified way of identifying at risk patients were put forward as important 
considerations for the long term sustainability of the PINCER intervention. Furthermore, 
some modifications to the PINCER intervention in terms of improving the specificity and 
variety of indicators available was suggested by participants.   
  
Conclusions  
  
PINCER has been widely implemented across general practices in the East Midlands with 
modest reductions in hazardous prescribing, with the greatest differences demonstrated for 
prescribing safety indicators associated with gastrointestinal bleeding. The extent to which 
stakeholders engage with PINCER at different stages of implementation is a crucial factor 
for PINCER uptake, use and sustainability. The intervention is likely to be even more 
acceptable for wider use in general practice with some modifications to IT making it easier 
to identify at risk patients; having access to adequate resources (particularly time for 
pharmacists), and more information on the potential for PINCER to provide cost-savings 
through reductions in hospital admissions.     
